Low-grade salivary duct carcinoma: Description of 16 cases

American Journal of Surgical Pathology

Volumn 28, Issue 8, 2004, Pages 1040-1044

  Brandwein Gensler, Margaret ^a   Hille, Jos ^a,e   Wang, Beverly Y ^a   Urken, Mark ^a   Gordon, Ronald ^a   Wang, Li Juan ^b   Simpson, James R M ^c   Simpson, Roderick H W ^d   Gnepp, Douglas R ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c ST RICHARD S HOSPITAL   (United Kingdom)

^d ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^e UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Carcinoma; Cribriform; Cystadenocarcinoma; Duct; Low grade; Salivary

Indexed keywords

CALPONIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEU DIFFERENTIATION FACTOR; PROTEIN S 100;

ADULT; AGED; ARTICLE; BREAST DUCT HYPERPLASIA; CANCER GRADING; CANCER INVASION; CHROMATIN; CLINICAL ARTICLE; CYST; CYSTADENOCARCINOMA; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERPLASIA; INTRADUCTAL CARCINOMA; MALE; MITOSIS INDEX; MITOTIC FIGURE; MYOEPITHELIUM CELL; NUCLEOLUS; PAPILLOCYSTIC ACINIC CELL CARCINOMA; PAROTID GLAND CANCER; PROGNOSIS; RARE DISEASE; SALIVARY GLAND DUCT; SALIVARY GLAND DUCT CARCINOMA; SALIVARY GLAND TUMOR; STROMA; SUBMANDIBULAR GLAND; TUMOR NECROSIS;

AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CYSTADENOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; S100 PROTEINS; SALIVARY DUCTS; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 3242812652     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000128662.66321.be     Document Type: Article

References (12)

1. Anderson C, Muller R, Piorkowski R, et al. Intraductal carcinoma of major salivary gland. Cancer. 1992;69:609-614.
2. Barnes L, Rao U, Krause J, et al. Salivary duct carcinoma: I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral Surg Oral Med Oral Pathol. 1994;78:64-73.
3. Barnes L, Rao U, Contis L, et al. Salivary duct carcinoma: II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol. 1994;78:74-80.
4. Brandwein MS, Jagirdar J, Patil J, et al. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts): a clinicopathologic and immunohistochemical study of 12 cases. Cancer. 1990;65:2307-2314.
5. Brandwein M, Gnepp DR. Low-grade cribriform cystadenocarcinoma. In: World Health Organization Classification of Head and Neck Tumors: Tumors of the Salvary Glands, Section 5.2. In press.
6. Deleted in proofs.
7. Delgado R, Klimstra D, Alboressaavedra J. Low grade salivary duct carcinoma: a distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 1996;78:958-967.
8. Delgado R, Vuitch F, Albores-Saavedra J. Salivary duct carcinoma. Cancer. 1993;72:1503-1512.
9. Foss RD, Ellis GL, Auclair PL. Salivary gland cystadenocarcinomas: a clinicopathologic study of 57 cases. Am J Surg Pathol. 1996;20:1440-1447.
10. Lewis JE, McKinney BC, Weiland LH. Salivary duct carcinoma: clinicopathologic and immunohistochemical review 26 cases. Cancer. 1996;77: 223-230.
11. Skálová A, Stárek I, Kučerová V, et al. Salivary duct carcinoma: a highly aggressive salivary gland tumor with HER-2/oncoprotein overexpression. Pathol Res Pract. 2001;197:621-626.
12. Tatemoto Y, Ohno A, Osaki T. Low malignant intraductal carcinoma on the hard palate: a variant of salivary duct carcinoma. Oral Oncol Eur J Cancer. 1996;32B:275-277.